耐受性-话题@MedSci

#耐受性#

144篇内容 | 4001人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1417738, encodeId=02a5141e73895, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=JBMR：唑来磷酸对脊髓损伤后骨质流失的耐受性和延迟治疗的效果, objectType=article, longId=219110, objectId=82b62191101a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82b62191101a, replyNumber=0, likeNumber=105, createdTime=2021-10-25, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82b62191101a, moduleTitle=JBMR：唑来磷酸对脊髓损伤后骨质流失的耐受性和延迟治疗的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82b62191101a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417736, encodeId=7474141e736df, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=ESMO Open：奥斯替尼联合铂-培美曲塞用于EGFR突变的NSCLC患者的安全性和耐受性, objectType=article, longId=217452, objectId=1a0421e45297, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a0421e45297, replyNumber=0, likeNumber=87, createdTime=2021-09-24, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a0421e45297, moduleTitle=ESMO Open：奥斯替尼联合铂-培美曲塞用于EGFR突变的NSCLC患者的安全性和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a0421e45297)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417735, encodeId=ee90141e735d8, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Nat Commun：小檗碱治疗非酒精性脂肪性肝炎和2型糖尿病具有良好的耐受性, objectType=article, longId=217319, objectId=8c1321e31970, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c1321e31970, replyNumber=0, likeNumber=78, createdTime=2021-09-20, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c1321e31970, moduleTitle=Nat Commun：小檗碱治疗非酒精性脂肪性肝炎和2型糖尿病具有良好的耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c1321e31970)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417734, encodeId=d241141e734dd, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle= J Eur Acad Dermatol Venereol：对于6月至6岁的严重未受控制的特应性皮炎儿童，单剂量度匹鲁单抗的耐受性良好, objectType=article, longId=215618, objectId=f1682156183c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1682156183c, replyNumber=0, likeNumber=70, createdTime=2021-08-13, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1682156183c, moduleTitle= J Eur Acad Dermatol Venereol：对于6月至6岁的严重未受控制的特应性皮炎儿童，单剂量度匹鲁单抗的耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1682156183c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417733, encodeId=364d141e7335f, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=J Invest Dermatol：PF-06700841对中重度斑块状银屑病患者普遍有效且耐受性良好, objectType=article, longId=210778, objectId=b052210e782f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b052210e782f, replyNumber=0, likeNumber=104, createdTime=2021-05-05, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b052210e782f, moduleTitle=J Invest Dermatol：PF-06700841对中重度斑块状银屑病患者普遍有效且耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b052210e782f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417732, encodeId=cadc141e732ce, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Pediatr Blood Cancer：放疗联合VPA和贝伐珠单抗治疗胶质瘤的耐受性良好, objectType=article, longId=209932, objectId=aace20993238, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aace20993238, replyNumber=0, likeNumber=73, createdTime=2021-04-15, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aace20993238, moduleTitle=Pediatr Blood Cancer：放疗联合VPA和贝伐珠单抗治疗胶质瘤的耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aace20993238)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417731, encodeId=48a2141e731e7, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=PLOS Med：止吐、镇痛、抗炎……药用大麻素的安全性和耐受性分析, objectType=article, longId=209606, objectId=6ebb2096060a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ebb2096060a, replyNumber=0, likeNumber=79, createdTime=2021-04-08, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ebb2096060a, moduleTitle=PLOS Med：止吐、镇痛、抗炎……药用大麻素的安全性和耐受性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ebb2096060a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417730, encodeId=6b18141e73028, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=PLOS Med：止吐、镇痛、抗炎……药用大麻素的安全性和耐受性分析, objectType=article, longId=209593, objectId=f81d20959369, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f81d20959369, replyNumber=0, likeNumber=71, createdTime=2021-04-07, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f81d20959369, moduleTitle=PLOS Med：止吐、镇痛、抗炎……药用大麻素的安全性和耐受性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f81d20959369)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417729, encodeId=a824141e7291c, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=ASH 2020：Calquence治疗MCL的长期疗效和耐受性, objectType=article, longId=204329, objectId=16ec20432946, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16ec20432946, replyNumber=0, likeNumber=96, createdTime=2020-12-10, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16ec20432946, moduleTitle=ASH 2020：Calquence治疗MCL的长期疗效和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16ec20432946)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417728, encodeId=e279141e728fe, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Blood：Umbralisib用于BTK或PI3Kδ抑制剂不耐受的CLL患者的疗效和耐受性, objectType=article, longId=204131, objectId=bf81204131cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf81204131cf, replyNumber=0, likeNumber=77, createdTime=2020-12-06, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf81204131cf, moduleTitle=Blood：Umbralisib用于BTK或PI3Kδ抑制剂不耐受的CLL患者的疗效和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf81204131cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417727, encodeId=5bcb141e727a0, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Medicine (Baltimore)：来福林 vs. 莫西沙星治疗社区获得性细菌性肺炎患者的临床疗效和耐受性, objectType=article, longId=204118, objectId=286220411867, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=286220411867, replyNumber=0, likeNumber=69, createdTime=2020-12-05, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=286220411867, moduleTitle=Medicine (Baltimore)：来福林 vs. 莫西沙星治疗社区获得性细菌性肺炎患者的临床疗效和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=286220411867)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417726, encodeId=1d92141e726d4, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Clinical Nutrition: 胃切除术后早期口服肠内营养的耐受性及预测肠衰竭的危险因素, objectType=article, longId=203445, objectId=ad2a2034458f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad2a2034458f, replyNumber=0, likeNumber=110, createdTime=2020-11-17, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad2a2034458f, moduleTitle=Clinical Nutrition: 胃切除术后早期口服肠内营养的耐受性及预测肠衰竭的危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad2a2034458f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417725, encodeId=8350141e72560, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Br J Clin Pharmacol：HPV疫苗在男性中安全耐受性良好，HPV疫苗之父：男性也应接种, objectType=article, longId=202983, objectId=5e91202983bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e91202983bf, replyNumber=0, likeNumber=80, createdTime=2020-11-08, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e91202983bf, moduleTitle=Br J Clin Pharmacol：HPV疫苗在男性中安全耐受性良好，HPV疫苗之父：男性也应接种, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e91202983bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417724, encodeId=0069141e724b5, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Lancet Neurology：口服Atogepant预防成人发作性偏头痛的安全性、耐受性和有效性:一项双盲、随机2b/3期试验 , objectType=article, longId=202722, objectId=b0d1202e22f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0d1202e22f8, replyNumber=0, likeNumber=67, createdTime=2020-11-02, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0d1202e22f8, moduleTitle=Lancet Neurology：口服Atogepant预防成人发作性偏头痛的安全性、耐受性和有效性:一项双盲、随机2b/3期试验 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0d1202e22f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417723, encodeId=bfbf141e723be, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Clin Infect Dis：来氟米林治疗社区获得性细菌性肺炎的效果不劣于莫西沙星，且耐受性良好, objectType=article, longId=201780, objectId=b102201e8073, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b102201e8073, replyNumber=0, likeNumber=78, createdTime=2020-10-08, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b102201e8073, moduleTitle=Clin Infect Dis：来氟米林治疗社区获得性细菌性肺炎的效果不劣于莫西沙星，且耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b102201e8073)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417722, encodeId=8793141e72225, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Clin Lung Cancer：Atezolizumab可有效治疗日本广泛期小细胞肺癌患者，且耐受性良好, objectType=article, longId=201761, objectId=5d9d201e6149, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d9d201e6149, replyNumber=0, likeNumber=113, createdTime=2020-10-07, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d9d201e6149, moduleTitle=Clin Lung Cancer：Atezolizumab可有效治疗日本广泛期小细胞肺癌患者，且耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d9d201e6149)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417721, encodeId=8f47141e7218a, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Benef Microbes：LAB胶囊具有良好的耐受性，可作为恢复性活跃女性阴道乳酸菌的适当替代品, objectType=article, longId=201733, objectId=96b9201e33f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96b9201e33f9, replyNumber=0, likeNumber=60, createdTime=2020-10-07, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96b9201e33f9, moduleTitle=Benef Microbes：LAB胶囊具有良好的耐受性，可作为恢复性活跃女性阴道乳酸菌的适当替代品, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96b9201e33f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417720, encodeId=cd37141e7206e, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Ann Oncol：曲拉西利布可改善对患者化疗的耐受性, objectType=article, longId=201445, objectId=10fa20144543, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10fa20144543, replyNumber=0, likeNumber=158, createdTime=2020-10-02, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10fa20144543, moduleTitle=Ann Oncol：曲拉西利布可改善对患者化疗的耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10fa20144543)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417719, encodeId=a940141e7190b, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=NEJM：免疫治疗时代的耐受性, objectType=article, longId=201373, objectId=003e2013e362, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=003e2013e362, replyNumber=0, likeNumber=55, createdTime=2020-10-01, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=003e2013e362, moduleTitle=NEJM：免疫治疗时代的耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=003e2013e362)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417718, encodeId=ddf6141e71862, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Lancet Neurology：口服Atogepant治疗成人发作性偏头痛的安全性、耐受性和有效性：一项双盲、随机2b/3期试验, objectType=article, longId=199902, objectId=ebc019990227, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebc019990227, replyNumber=0, likeNumber=69, createdTime=2020-08-26, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebc019990227, moduleTitle=Lancet Neurology：口服Atogepant治疗成人发作性偏头痛的安全性、耐受性和有效性：一项双盲、随机2b/3期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebc019990227)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

耐受性

2020-05-29

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

JBMR：唑来磷酸对脊髓损伤后骨质流失的耐受性和延迟治疗的效果

2021-10-25

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

ESMO Open：奥斯替尼联合铂-培美曲塞用于EGFR突变的NSCLC患者的安全性和耐受性

2021-09-24

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Nat Commun：小檗碱治疗非酒精性脂肪性肝炎和2型糖尿病具有良好的耐受性

2021-09-20

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

J Eur Acad Dermatol Venereol：对于6月至6岁的严重未受控制的特应性皮炎儿童，单剂量度匹鲁单抗的耐受性良好

2021-08-13

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

J Invest Dermatol：PF-06700841对中重度斑块状银屑病患者普遍有效且耐受性良好

2021-05-05

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Pediatr Blood Cancer：放疗联合VPA和贝伐珠单抗治疗胶质瘤的耐受性良好

2021-04-15

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

PLOS Med：止吐、镇痛、抗炎……药用大麻素的安全性和耐受性分析

2021-04-08

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

PLOS Med：止吐、镇痛、抗炎……药用大麻素的安全性和耐受性分析

2021-04-07

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

ASH 2020：Calquence治疗MCL的长期疗效和耐受性

2020-12-10

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Blood：Umbralisib用于BTK或PI3Kδ抑制剂不耐受的CLL患者的疗效和耐受性

2020-12-06

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Medicine (Baltimore)：来福林 vs. 莫西沙星治疗社区获得性细菌性肺炎患者的临床疗效和耐受性

2020-12-05

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Clinical Nutrition: 胃切除术后早期口服肠内营养的耐受性及预测肠衰竭的危险因素

2020-11-17

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Br J Clin Pharmacol：HPV疫苗在男性中安全耐受性良好，HPV疫苗之父：男性也应接种

2020-11-08

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Lancet Neurology：口服Atogepant预防成人发作性偏头痛的安全性、耐受性和有效性:一项双盲、随机2b/3期试验

2020-11-02

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Clin Infect Dis：来氟米林治疗社区获得性细菌性肺炎的效果不劣于莫西沙星，且耐受性良好

2020-10-08

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Clin Lung Cancer：Atezolizumab可有效治疗日本广泛期小细胞肺癌患者，且耐受性良好

2020-10-07

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Benef Microbes：LAB胶囊具有良好的耐受性，可作为恢复性活跃女性阴道乳酸菌的适当替代品

2020-10-07

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Ann Oncol：曲拉西利布可改善对患者化疗的耐受性

2020-10-02

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

NEJM：免疫治疗时代的耐受性

2020-10-01

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Lancet Neurology：口服Atogepant治疗成人发作性偏头痛的安全性、耐受性和有效性：一项双盲、随机2b/3期试验

2020-08-26

科室
- - 订阅+
  - 更多科室
工具
服务